Currently, there are 99.70M common shares owned by the public and among those 92.69M shares have been available to trade.
The company’s stock has a 5-day price change of 9.49% and 59.23% over the past three months. SG shares are trading 238.05% year to date (YTD), with the 12-month market performance up to 229.31% higher. It has a 12-month low price of $8.64 and touched a high of $38.53 over the same period. SG has an average intraday trading volume of 3.42 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 9.01%, 16.55%, and 57.91% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Sweetgreen Inc (NYSE: SG) shares accounts for 82.53% of the company’s 99.70M shares outstanding.
It has a market capitalization of $4.36B and a beta (3y monthly) value of 2.34. The earnings-per-share (ttm) stands at -$0.83. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.77% over the week and 6.10% over the month.
Earnings per share for the fiscal year are expected to increase by 29.90%, and 38.17% over the next financial year. EPS should grow at an annualized rate of 27.00% over the next five years, compared to -12.71% over the past 5-year period.
Looking at the support for the SG, a number of firms have released research notes about the stock. TD Cowen stated their Buy rating for the stock in a research note on September 04, 2024, with the firm’s price target at $31-$43. Piper Sandler coverage for the Sweetgreen Inc (SG) stock in a research note released on August 19, 2024 offered a Neutral rating with a price target of $39. UBS was of a view on July 17, 2024 that the stock is Buy, while Morgan Stanley gave the stock Equal-Weight rating on July 16, 2024, issuing a price target of $25. Goldman on their part issued Buy rating on June 13, 2024.
